Technology · 1 sources covering this

AI Life Science Firm Metis TechBio Set for HK Debut After IPO

Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs, is set to begin trading in Hong Kong after raising HK$2.1 billion ($270 million) in an initial public offering.

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·1h ago
AI Life Science Firm Metis TechBio Set for HK Debut After IPO
Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs, is set to begin trading in Hong Kong after raising HK$2.1 billion ($270 million) in an initial public offering.
Read at Bloomberg →

AI Life Science Firm Metis TechBio Set for HK Debut After IPO

How 1 sources are covering this

AI Life Science Firm Metis TechBio Set for HK Debut After IPO

More from Technology

Anthropic in Talks to Raise Funding at a $950 Billion Valuation

Alibaba, Tencent AI Bets Face ‘Show Me the Profits’ Scrutiny

Musk Lawyer’s Question for Sam Altman on the Stand: Are You Trustworthy?

1789 Capital’s Abrahimzadeh on SpaceX, Cerebras Ipos

Reader

Trust & legal

Across the network